Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients
Crossref DOI link: https://doi.org/10.1007/s00280-017-3474-7
Published Online: 2017-11-27
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Andel, L. http://orcid.org/0000-0002-2285-3384
Rosing, H.
Zhang, Z.
Hughes, L.
Kansra, V.
Sanghvi, M.
Tibben, M. M.
Gebretensae, A.
Schellens, J. H. M.
Beijnen, J. H.
License valid from 2017-11-27